mTOR is a downstream regulator of the PI3K/AKT/mTOR pathway and is a known target for cancer therapy, and mTOR inhibition leads to the blockade of downstream pathways, controls the cell cycle, and ultimately leads to cell cycle arrest (62). Here, MTOR is linked to cancer.